180 Life Sciences EV/EBIT
¿Qué es el EV/EBIT de 180 Life Sciences?
El EV/EBIT de 180 Life Sciences Corp. es N/A
¿Cuál es la definición de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de compañías en Sector Health Care en NASDAQ en comparadas con 180 Life Sciences
¿Qué hace 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Empresas con ev/ebit similar a 180 Life Sciences
- Asensus Surgical Inc tiene EV/EBIT de N/A
- Aurelius Minerals tiene EV/EBIT de N/A
- Pintec Technology Ltd tiene EV/EBIT de N/A
- Spherix tiene EV/EBIT de N/A
- DiscovEx Resources tiene EV/EBIT de N/A
- Superconductor Technologies tiene EV/EBIT de N/A
- 180 Life Sciences tiene EV/EBIT de N/A
- Westar Resources tiene EV/EBIT de N/A
- Chaparral tiene EV/EBIT de N/A
- Katoro Gold plc tiene EV/EBIT de N/A
- Synairgen plc tiene EV/EBIT de N/A
- Graycliff Exploration tiene EV/EBIT de N/A
- DBV Technologies tiene EV/EBIT de N/A